Bioceres Crop Solutions Receives Green Light for Cultivation of Drought Tolerant HB4 Wheat in the United States
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) has received approval from the USDA for the cultivation of its HB4 drought-tolerant wheat in the United States. The USDA's Animal and Plant Health Inspection Service (APHIS) concluded that HB4 wheat does not pose an increased plant pest risk compared to conventional wheat. This decision complements the FDA's previous favorable review for food and feed use.
The United States, the fourth-largest wheat producer globally, joins Argentina, Brazil, and Paraguay in approving HB4 wheat production. Several other countries have approved the technology for food and feed use. Bioceres is also pursuing field trials in Australia for potential production approval. The company will provide more details on its HB4 wheat platform during its upcoming Earnings Call on September 10th.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) ha ricevuto l'approvazione dal USDA per la coltivazione del suo grano resistente alla siccità HB4 negli Stati Uniti. Il Servizio di Ispezione della Salute degli Animali e delle Piante (APHIS) del USDA ha concluso che il grano HB4 non presenta un rischio maggiore di parassiti delle piante rispetto al grano convenzionale. Questa decisione si aggiunge alla precedente revisione favorevole della FDA per l'uso alimentare e per mangimi.
Gli Stati Uniti, il quarto produttore di grano a livello globale, si uniscono ad Argentina, Brasile e Paraguay nell'approvazione della produzione di grano HB4. Diversi altri paesi hanno approvato la tecnologia per l'uso alimentare e per mangimi. Bioceres sta anche perseguendo prove sul campo in Australia per l'approvazione della produzione. L'azienda fornirà ulteriori dettagli sulla sua piattaforma di grano HB4 durante la prossima Earnings Call del 10 settembre.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) ha recibido la aprobación del USDA para el cultivo de su trigo resistente a la sequía HB4 en Estados Unidos. El Servicio de Inspección de Salud Animal y Vegetal (APHIS) del USDA concluyó que el trigo HB4 no representa un riesgo mayor de plagas en comparación con el trigo convencional. Esta decisión complementa la revisión favorable previa de la FDA para su uso en alimentos y piensos.
Los Estados Unidos, el cuarto productor de trigo a nivel mundial, se une a Argentina, Brasil y Paraguay en la aprobación de la producción de trigo HB4. Varios otros países han aprobado la tecnología para uso en alimentos y piensos. Bioceres también está llevando a cabo ensayos de campo en Australia para una posible aprobación de producción. La empresa proporcionará más detalles sobre su plataforma de trigo HB4 durante su próxima Earnings Call el 10 de septiembre.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX)는 미국에서 HB4 가뭄 저항 밀 재배를 위해 USDA의 승인을 받았습니다. USDA의 동식물검역국 (APHIS)은 HB4 밀이가 기존 밀에 비해 식물 해충 위험을 증가시키지 않는다고 결론지었습니다. 이 결정은 FDA의 식품 및 사료 사용에 대한 이전의 긍정적 검토를 보완합니다.
미국은 글로벌 밀 생산 4위 국가로서 아르헨티나, 브라질, 파라과이와 함께 HB4 밀 생산을 승인하게 되었습니다. 여러 다른 국가들도 이 기술을 식품 및 사료용으로 승인했습니다. Bioceres는 또한 호주에서 잠재적인 생산 승인을 얻기 위한 필드 시험을 진행하고 있습니다. 이 회사는 9월 10일 예정된 Earnings Call에서 HB4 밀 플랫폼에 대한 자세한 정보를 제공할 예정입니다.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) a reçu l'approbation du USDA pour la culture de son blé résistant à la sécheresse HB4 aux États-Unis. Le Service d'inspection de la santé animale et végétale (APHIS) du USDA a conclu que le blé HB4 ne présente pas de risque accru de parasites végétaux par rapport au blé conventionnel. Cette décision complète la révision favorable antérieure de la FDA pour l'utilisation alimentaire et animale.
Les États-Unis, le quatrième producteur mondial de blé, rejoignent l'Argentine, le Brésil et le Paraguay dans l'approbation de la production de blé HB4. Plusieurs autres pays ont approuvé la technologie pour une utilisation alimentaire et animale. Bioceres poursuit également des essais sur le terrain en Australie pour une éventuelle approbation de production. L'entreprise fournira plus de détails sur sa plateforme de blé HB4 lors de sa prochaine Earnings Call le 10 septembre.
Die Bioceres Crop Solutions Corp. (NASDAQ: BIOX) hat die Genehmigung des USDA für den Anbau ihres HB4 trockenheitsresistenten Weizens in den Vereinigten Staaten erhalten. Der Animal and Plant Health Inspection Service (APHIS) des USDA kam zu dem Schluss, dass HB4-Weizen im Vergleich zu herkömmlichem Weizen kein erhöhtes Risiko von Pflanzenkrankheiten darstellt. Diese Entscheidung ergänzt die zuvor positive Bewertung der FDA für die Verwendung in Lebensmitteln und Futtermitteln.
Die Vereinigten Staaten, der viertgrößte Weizenproduzent weltweit, schließen sich Argentinien, Brasilien und Paraguay bei der Genehmigung der HB4-Weizenproduktion an. Mehrere andere Länder haben die Technologie für die Verwendung in Lebensmitteln und Futtermitteln genehmigt. Bioceres verfolgt auch Feldversuche in Australien, um eine mögliche Produktionsgenehmigung zu erhalten. Das Unternehmen wird während seiner bevorstehenden Earnings Call am 10. September weitere Details zu seiner HB4-Weizenplattform bekannt geben.
- USDA approval for HB4 wheat cultivation in the United States
- Expansion of HB4 wheat production to the fourth-largest wheat producer globally
- Complementary to FDA's previous favorable review for food and feed use
- Approval for production in four countries (US, Argentina, Brazil, Paraguay)
- Food and feed use approvals in multiple countries
- None.
The USDA's approval of HB4 wheat for cultivation in the U.S. marks a significant milestone for Bioceres Crop Solutions. This drought-tolerant technology addresses a critical need in agriculture, especially as climate change impacts crop yields. The U.S., being the fourth-largest wheat producer globally, offers a substantial market opportunity.
However, market adoption may face challenges. Consumers and some export markets have shown resistance to genetically modified wheat. The success of HB4 wheat will depend on farmer acceptance, regulatory approvals in key export markets and consumer perception. The technology's potential to improve yields in water-stressed conditions could be a game-changer, particularly in drought-prone regions.
This approval opens up a significant market opportunity for Bioceres. The U.S. wheat market was valued at
However, adoption rates for new crop technologies can be slow. It typically takes 3-5 years for widespread adoption. The company will need to demonstrate clear yield advantages and economic benefits to farmers. The global reach of this technology, with approvals in 12 countries, including major wheat producers like Argentina and Brazil, suggests potential for significant international growth as well.
HB4 wheat represents a potential solution to the growing challenge of water scarcity in agriculture. With climate change intensifying drought conditions worldwide, crops that can maintain yields under water stress are increasingly valuable. This technology could help reduce water usage in wheat production, a critical factor as freshwater resources become scarcer.
However, the long-term environmental impacts of widespread adoption of genetically modified wheat need careful monitoring. While the USDA has determined it doesn't pose increased plant pest risk, ongoing studies will be important to assess any unforeseen ecological effects. The technology's potential to improve food security in drought-prone regions is significant, but balanced against the need for crop diversity and sustainable farming practices.
The USDA, through the Animal and Plant Health Inspection Service (APHIS), reviewed HB4 wheat and concluded that it does not pose an increased plant pest risk relative to comparator wheat plants. As such, it is not subject to regulations under the 7 CFR part 340 for organisms modified or produced through genetic engineering.
The determination clears the U.S. market for production of HB4 wheat and complements the FDA’s previously obtained favorable review for food and feed use.
The company will provide further details on its HB4 wheat platform during its upcoming Earnings Call, to be held on Tuesday, September 10th at 8:30 a.m. EST.
About Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp. (NASDAQ: BIOX) is a leader in the development and commercialization of productivity solutions designed to regenerate agricultural ecosystems while making crops more resilient to climate change. To do this, Bioceres’ solutions create economic incentives for farmers and other stakeholders to adopt environmentally friendlier production practices. The Company has a unique biotech platform with high-impact, patented technologies for seeds and microbial ag-inputs, as well as next generation crop nutrition and protection solutions. Through its HB4 program, the Company is bringing digital solutions to support growers’ decisions and provide end-to-end traceability for production outputs. For more information, visit here.
Forward-looking statements
This communication includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “believe,” “expect,” “estimate,” “plan,” “outlook,” and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements are based on management’s reasonable current assumptions, expectations, plans and forecasts regarding the Company’s current or future results and future business and economic conditions more generally. Such forward-looking statements involve risks, uncertainties and other factors, which may cause the actual results, levels of activity, performance or achievement of the Company to be materially different from any future results expressed or implied by such forward-looking statements, and there can be no assurance that actual results will not differ materially from management’s expectations or could affect the Company’s ability to achieve its strategic goals, including the uncertainties relating to the impact of COVID-19 on the Company’s business, operations, liquidity and financial results and the other factors that are described in the sections entitled “Risk Factors” in the Company's Securities and Exchange Commission filings updated from time to time. The preceding list is not intended to be an exhaustive list of all of our forward-looking statements. Therefore, you should not rely on any of these forward-looking statements as predictions of future events. All forward-looking statements contained in this release are qualified in their entirety by this cautionary statement. Forward-looking statements speak only as of the date they are or were made, and the Company does not intend to update or otherwise revise the forward-looking statements to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, except as required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240828585854/en/
Bioceres Crop Solutions
Paula Savanti
Head of Investor Relations
investorrelations@biocerescrops.com
Source: Bioceres Crop Solutions Corp.
FAQ
What is the latest regulatory approval for Bioceres Crop Solutions' HB4 wheat?
How many countries have approved Bioceres' HB4 wheat for production as of September 2023?
What is the significance of the US market for Bioceres' HB4 wheat (BIOX)?
When will Bioceres Crop Solutions (BIOX) provide more details on its HB4 wheat platform?
What is the current status of HB4 wheat trials in Australia for Bioceres (BIOX)?
